Compounds > zanamivir

Page last updated: 2024-08-24

zanamivir and a 315675

zanamivir has been researched along with a 315675 in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (33.33)	29.6817
2010's	6 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kati, WM; Kempf, DJ; Kohlbrenner, WE; Krueger, AC; Maring, CJ; McDaniel, KF; Molla, A; Montgomery, D; Xu, Y	1
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E	1
Demmler-Harrison, GJ; Deyde, VM; Gubareva, LV; Klimov, AI; Okomo-Adhiambo, M; Sheu, TG; Xu, X	1
Gubareva, LV; Klimov, AI; Mishin, VP; Nguyen, HT; Sheu, TG	1
Bhatt, B; Böhm, R; Dyason, JC; Kerry, PS; Russell, RJ; Thomson, RJ; von Itzstein, M	1
Carrick, R; Gusick, N; Kati, W; Kempf, DJ; Kohlbrenner, W; Maring, C; Molla, A; Montgomery, D; Ng, TI; Shi, Y; Steffy, K; Stewart, KD; Stoll, VS	1
Abed, Y; Boivin, G; Bouhy, X; Pizzorno, A	1
Deyde, VM; Fry, AM; Garten, RJ; Gubareva, LV; Klimov, AI; Mishin, VP; Nguyen, HT; Okomo-Adhiambo, M; Shaw, MW; Sheu, TG; Sleeman, K; Trujillo, AA	1
Li, JF; Shen, JS; Xiong, RS; Zhang, Q; Zhao, QJ	1

Reviews

1 review(s) available for zanamivir and a 315675

Article	Year
[Research progress of anti-influenza virus agents]. Yao xue xue bao = Acta pharmaceutica Sinica, 2010, Volume: 45, Issue:3 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Guanidines; Humans; Indoles; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Pyrrolidines; Rimantadine; Structure-Activity Relationship; Viral Matrix Proteins; Zanamivir	2010

Other Studies

8 other study(ies) available for zanamivir and a 315675

Article	Year
Synthesis of potent pyrrolidine influenza neuraminidase inhibitors. Bioorganic & medicinal chemistry letters, 2008, Mar-01, Volume: 18, Issue:5 Topics: Antiviral Agents; Influenza A virus; Influenza B virus; Molecular Structure; Neuraminidase; Pyrrolidines; Structure-Activity Relationship	2008
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2 Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship	2009
Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Antiviral Agents; Cells, Cultured; Child, Preschool; Drug Resistance, Viral; Genetic Testing; Humans; Immunocompromised Host; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Molecular Sequence Data; Neuraminidase; Oseltamivir; Point Mutation; Sequence Analysis, DNA	2010
Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Acids, Carbocyclic; Animals; Cell Line; Cyclopentanes; Dogs; Enzyme Assays; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Inhibitory Concentration 50; Neuraminidase; Oseltamivir; Zanamivir	2010
Exploring the interactions of unsaturated glucuronides with influenza virus sialidase. Journal of medicinal chemistry, 2012, Oct-25, Volume: 55, Issue:20 Topics: Acetamides; Antiviral Agents; Catalytic Domain; Enzyme Assays; Fluorometry; Glucuronides; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Neuraminidase; Orthomyxoviridae; Static Electricity; Structure-Activity Relationship	2012
In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675. Journal of virology, 2002, Volume: 76, Issue:11 Topics: Acetamides; Animals; Antiviral Agents; Cell Line; Dogs; Drug Resistance, Viral; Enzyme Inhibitors; Genetic Variation; Guanidines; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A virus; Mutagenesis; Neuraminidase; Oseltamivir; Phenotype; Pyrans; Pyrrolidines; Sialic Acids; Zanamivir	2002
Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors. The Journal of infectious diseases, 2011, Jan-01, Volume: 203, Issue:1 Topics: Acids, Carbocyclic; Amino Acid Substitution; Antiviral Agents; Cyclopentanes; Drug Resistance, Viral; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Neuraminidase; Oseltamivir; Pyrrolidines; Recombination, Genetic; Viral Plaque Assay; Viral Proteins; Virus Replication; Zanamivir	2011
Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro. Antiviral therapy, 2010, Volume: 15, Issue:8 Topics: Acids, Carbocyclic; Adamantane; Amino Acid Substitution; Animals; Antiviral Agents; Cell Line; Cyclopentanes; Dogs; Drug Resistance, Viral; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Neuraminidase; Oseltamivir; Pyrans; Pyrrolidines; Sialic Acids; Viral Plaque Assay; Zanamivir	2010